Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study
Clinical trial registration, sponsored by Yale University, registered 29 Nov 2017.
Phase 1 · completed · n = 28
Tags: Registry, Psilocybin, OCD.
Results posted for Yale's double-blind psilocybin trial in obsessive-compulsive disorder, now completed
How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)
Read the original
